Omega Therapeutics Company Insiders

OMGA Stock  USD 0.47  0.02  4.08%   
Omega Therapeutics employs about 93 people. The company is managed by 16 executives with a total tenure of roughly 217 years, averaging almost 13.0 years of service per executive, having 5.81 employees per reported executive. Analysis of Omega Therapeutics' management performance can provide insight into the company performance.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For information on how to trade Omega Stock refer to our How to Trade Omega Stock guide.

Omega Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.2537) % which means that it has lost $0.2537 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2915) %, meaning that it created substantial loss on money invested by shareholders. Omega Therapeutics' management efficiency ratios could be used to measure how well Omega Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.

Omega Therapeutics Workforce Comparison

Omega Therapeutics is regarded second in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 945. Omega Therapeutics holds roughly 93.0 in number of employees claiming about 10% of equities under Health Care industry.

Omega Therapeutics Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Omega Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Omega Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Omega Therapeutics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Omega Therapeutics Notable Stakeholders

An Omega Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Omega Therapeutics often face trade-offs trying to please all of them. Omega Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Omega Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Mahesh KarandeCEO PresidentProfile
JD EsqChief SecretaryProfile
Kevin McManusChief OfficerProfile
Kaan CertelChief OfficerProfile
Barbara ChanPrincipal OfficeProfile
Noubar AfeyanCoFounder ChairmanProfile
Jennifer NelsonSenior ResearchProfile
Joshua MBAChief OfficerProfile
Lisamarie FahySenior OperationsProfile
Sivakesava SakhamuriSenior QualityProfile
Anthony MullinChief OfficerProfile
Yan MDChief OfficerProfile
Eva StroynowskiSenior AffairsProfile
Charles ODonnellVP SciencesProfile
Thomas McCauleyChief OfficerProfile
Joe NewmanSenior DiscoveryProfile

About Omega Therapeutics Management Performance

The success or failure of an entity such as Omega Therapeutics often depends on how effective the management is. Omega Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Omega management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Omega management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. Omega Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 79 people.
Please note, the presentation of Omega Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Omega Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Omega Therapeutics' management manipulating its earnings.

Omega Therapeutics Workforce Analysis

Traditionally, organizations such as Omega Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Omega Therapeutics within its industry.

Omega Therapeutics Manpower Efficiency

Return on Omega Therapeutics Manpower

Revenue Per Employee33.3K
Revenue Per Executive193.4K
Net Loss Per Employee1M
Net Loss Per Executive6.1M
Working Capital Per Employee678.3K
Working Capital Per Executive3.9M

Complementary Tools for Omega Stock analysis

When running Omega Therapeutics' price analysis, check to measure Omega Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omega Therapeutics is operating at the current time. Most of Omega Therapeutics' value examination focuses on studying past and present price action to predict the probability of Omega Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omega Therapeutics' price. Additionally, you may evaluate how the addition of Omega Therapeutics to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Commodity Directory
Find actively traded commodities issued by global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Share Portfolio
Track or share privately all of your investments from the convenience of any device